POSTER SESSION VI Wednesday, February 15, 2006   —  1:00 - 4:00 PM Exhibit Level BREAST PATHOLOGY 25 D2-40 Expression In Cutaneous Angiosarcoma Arising After Radiotherapy Treatment Of Breast Carcinoma (110) YM El-Gohary, JF Silverman, RJ Poppiti, YL Liu, RS Saad - Allegheny General Hospital, Pittsburgh, PA; Mount Sinai Medical Center, Miami Beach, FL 26 Ki-67 Index Is Diagnostically Useful In Distinguishing Benign Fibroepithelial Lesions In Young Females (182) SJ Shin, PP Rosen - Weill Medical College of Cornell University, New York, NY 27 Evaluation of the Relationships Between pAkt and Beta-catenin in Invasive Breast Carcinoma (173) RSJ Ricketts, R Gupta, SI Camelo, D Arabadjief, M Arabadjief, B Pazik, S Marconi, CN Otis - Baystate Medical Center, Springfield, MA 28 The Value Of Soy Isoflavones In Modulating Biomarkers Of Growth And Differentiation In Breast Cancer (86) O Basturk, NV Adsay, M Banerjee, L Newman, D Bouwman, D Doerge, Z Djuric, R Parchment, A Majumdar, F Miller, F Sarkar, O Kucuk - Wayne State Univ-Karmanos Cancer Inst, MI; Univ of Michigan, MI; National Center for Toxicologic Research, AR 29 Over-Expression of the N-myc Downstrean-Regulated Gene 1 (NDRG1) Is Associated with Poorer Prognosis in Breast Cancer (154) MA Nagai, IN Nishimoto, M Moura' Neto, OP Santos, FA Soares - Faculty of Medicine, University of Sao Paulo, Hospital do Cancer, Sao Paulo, Brazil 30 Progesterone Receptor Immunohistochemistry Of Antibody Clones PRA, PRB And PRAB: Correlation With Tumor Characteristics And Outcome In Breast Cancer (156) A Nassar, SM Waldrop, C Cohen - Emory University Hospital, Atlanta, GA 31 Molecular Markers In Usual Ductal Hyperplasias From Aesthetic Mammaplasty And Invasive Mammary Carcinoma Specimens (117) H Gobbi, LS Tafuri, GS Rocha - Federal University of Minas Gerais, Belo Horizonte, MG, Brazil 32 Evaulation of Phospho-mTOR (Mamalian Target of Rapamycin) Expression in Benign, Proliferative and Malignant Epithelial Lesions of the Breast (93) SI Camelo, R Ricketts, DA Arabadjief, MA Arabadjief, R Gupta, B Pacik, S Marconi, CN Otis - Baystate Medical Center, Springfield, MA 33 Immunohistochemical Distribution Of Thyroid Hormone Receptor In Non-Neoplastic Breast Tissue And Ductal Carcinoma (109) S Easley, FW Abdul-Karim, N Wang - Case Western Reserve University, Cleveland, OH 34 D310 Mitochondrial Genome Instability in the Development of Breast Cancer (191) J Vecchiarelli, NC Arneson, SJ Done - University of Toronto, University Health Network, Toronto, ON, Canada 35 Expression of Potassium Channels (KC) in Normal, Hyperplasic and Carcinomatous Breast Human Tissue (92) MA Brevet, HP Sevestre, A Ahidouch, PJ Merviel, Y Elhiani, H Ouadid-Ahidouch - Faculte des Sciences, Centre Hospitalier et Universitaire, Amiens, France, Metropolitan; Faculte des Sciences, Universite Ibn Zohr, Agadir, Morocco 36 CA IX is an Independent Predictor of Poor Prognosis in Breast Carcinoma: Results From a Population Based Study of 4150 Breast Cancers (99) BA Clarke, MC Cheang, A Rajput, SK Chia, CB Gilks, DG Huntsman - British Columbia Cancer Agency, Baystate Medical Center, Vancouver, BC, Canada 37 Activated IGF1R In Breast Cancer With Neoadjuvant Chemotherapy (163) G Peiró, FI Aranda, E Adrover, C Alenda, FM Peiró, A Payá - Hospital General Universitari, Alacant, Spain 38 Hyperphosphorylation Of Translational Repressor 4E-BP1 In Human Breast Is A Prognostic Factor (175) F Rojo, L Najera, J Lirola, J Jimenez, S Rodriguez, E Llonch, D Sabadell, J Baselga, S Ramon y Cajal - Vall D'Hebron Hospital, Barcelona, Spain 39 p16 (INK4a) Promoter Hypermethylation and Protein Expression in 140 Invasive Ductal NOS Carcinomas of the Breast (184) E Soria, JJ Sola, C Beorlegui, A Panizo, MA Idoate, FJ Pardo-Mindan - University of Navarra, Pamplona, Spain 40 The Protease Cathepsin K Is Highly Expressed In The Stroma Of Human Breast Cancers (134) SK Kraeft, LC Collins, SJ Schnitt - Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 41 Expression of Claudin 7, ZO-1 and SOX4 in Florid Hyperplasia and Breast Carcinoma (121) NM Granja, JF Simpson, P Wirth, ME Sanders - Vanderbilt University Medical Center, Nashville, TN 42 Expression of Protein Arginine Methyl Transferases in Mammary Ductal Carcinoma (193) J Wang, XM Zhang, B Singh, J Melamed, F Chen, P Lee, W Sun - New York University Medical Center, New York Harbor Healthcare System, New York, NY 43 Immunohistochemical Phenotype of Invasive Breast Carcinoma in Young Women. Correlation With COX-2 and PTEN Expression (168) M Planelles, FI Aranda, M Niveiro, G Peiro, C Alenda, J Segui, J Palacios - Hospital General Universitario, Alicante, Spain; Centro Nacional de Investigaciones Oncologicas, Madrid, Spain 44 Improved Detection of Breast Carcinoma Using Mammaglobin and Gross Cystic Disease Fluid Protein-15 (GCDFP-15) by Immunohistochemistry (189) CH Tse, TS Barry, H Hwang, DO Treaba, AM Gown - PhenoPath Laboratories, PLLC and IMPRIS, Fred Hutchinson Cancer Research Center, Seattle, WA 45 Mammaglobin Versus GCDFP-15: An Immunohistologic Validation Survey For Sensitivity And Specificity (88) R Bhargava, DJ Dabbs - Magee-Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA 46 Expression of the Undifferentiated Cell Marker P63 in Primary Invasive Carcinomas of the Breast and Their Nodal Metastases (124) MJ Hayes, CG Kleer - University of Michigan, Ann Arbor, MI 47 Lack  of  EGFR  Gene  Amplification  for  Metaplastic  and Basal-like Breast Cancers Measured Using Dual-Probe FISH (178) CL Schiller, WG Watkin, WR Wiseman, SM Sitterding, K Sikka, EL Wiley, LK Diaz - Northwestern Memorial Hospital, Chicago, IL 48 Most Triple-Negative Invasive Breast Cancers Express a Basal/Myoepithelial Phenotype (119) C Gomez-Fernandez, AP Martin-Sebastiao, M Jorda, M Nassiri - University of Miami-Jackson Memorial Hospital, Miami, FL 49 Epidermal Growth Factor Receptor (EGFR) Protein Overexpression is Associated with Gene Amplification in Metaplastic Carcinomas of the Breast (MCB) (96) DA Chitale, M Akram, E Brogi, V Barbashina - Memorial Sloan-Kettering Cancer Center, New York, NY 50 Cytologic Features of Breast Cancers With a Basal Phenotype (147) L Mclendon, SE Pambuccian, M Mosunjac, MJ Lund, J Cole, T Tadros, G Birdsong, S Lau, GM Oprea-Ilies - Emory University Hospital Grady Campus, Atlanta, GA; Massachssets Institute of Technology, Boston, MA; Rollins School of Public Health of Emory University, GA; University of Minnesota, Minneapolis, MN 51 Clinicopathologic Significance of Basal-like Subtype in Breast Cancers: Comparison with Hormone Receptor and Her2/neu Overexpressing Phenotypes (133) MJ Kim, JY Ro, SH Ahn, HH Kim, SB Kim, GY Gong - Asan Medical Center, Seoul, Korea; The Methodist Hospital, Houston, TX 52 Immunohistochemical Characterization and Prognostic Significance of Basal Type of Invasive Ductal Carcinoma in Breast (132) A Kim, YS Lee, Z Zheng, E Bae, JB Lee, IS Kim - College of Medicine, Korea University, Seoul, Korea